502 related articles for article (PubMed ID: 16397505)
21. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
22. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
23. Shuttle of lentiviral vectors via transplanted cells in vivo.
Blömer U; Gruh I; Witschel H; Haverich A; Martin U
Gene Ther; 2005 Jan; 12(1):67-74. PubMed ID: 15385952
[TBL] [Abstract][Full Text] [Related]
24. The use of lentiviral vectors to obtain transgenic rats.
Remy S; Nguyen TH; Ménoret S; Tesson L; Usal C; Anegon I
Methods Mol Biol; 2010; 597():109-25. PubMed ID: 20013229
[TBL] [Abstract][Full Text] [Related]
25. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
26. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.
Stitz J; Mühlebach MD; Blömer U; Scherr M; Selbert M; Wehner P; Steidl S; Schmitt I; König R; Schweizer M; Cichutek K
Virology; 2001 Dec; 291(2):191-7. PubMed ID: 11878888
[TBL] [Abstract][Full Text] [Related]
27. Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors.
Rahim AA; Wong AM; Howe SJ; Buckley SM; Acosta-Saltos AD; Elston KE; Ward NJ; Philpott NJ; Cooper JD; Anderson PN; Waddington SN; Thrasher AJ; Raivich G
Gene Ther; 2009 Apr; 16(4):509-20. PubMed ID: 19158847
[TBL] [Abstract][Full Text] [Related]
28. Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro.
Teng Q; Garrity-Moses M; Federici T; Tanase D; Liu JK; Mazarakis ND; Azzouz M; Walmsley LE; Carlton E; Boulis NM
Neurobiol Dis; 2005 Dec; 20(3):694-700. PubMed ID: 16005636
[TBL] [Abstract][Full Text] [Related]
29. Single-dose lentiviral gene transfer for lifetime airway gene expression.
Stocker AG; Kremer KL; Koldej R; Miller DS; Anson DS; Parsons DW
J Gene Med; 2009 Oct; 11(10):861-7. PubMed ID: 19634193
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
31. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
[TBL] [Abstract][Full Text] [Related]
32. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection.
Schroers R; Davis CM; Wagner HJ; Chen SY
Gene Ther; 2002 Jul; 9(13):889-97. PubMed ID: 12080383
[TBL] [Abstract][Full Text] [Related]
33. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
34. Gene transfer vectors derived from equine infectious anemia virus.
Olsen JC
Gene Ther; 1998 Nov; 5(11):1481-7. PubMed ID: 9930301
[TBL] [Abstract][Full Text] [Related]
35. Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation.
Schauber-Plewa C; Simmons A; Tuerk MJ; Pacheco CD; Veres G
Gene Ther; 2005 Feb; 12(3):238-45. PubMed ID: 15550926
[TBL] [Abstract][Full Text] [Related]
36. Use of HIV as a gene transfer vector.
Pluta K; Kacprzak MM
Acta Biochim Pol; 2009; 56(4):531-95. PubMed ID: 19936329
[TBL] [Abstract][Full Text] [Related]
37. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
39. Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography.
Scherr M; Battmer K; Eder M; Schüle S; Hohenberg H; Ganser A; Grez M; Blömer U
Gene Ther; 2002 Dec; 9(24):1708-14. PubMed ID: 12457285
[TBL] [Abstract][Full Text] [Related]
40. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
Mitta B; Weber CC; Rimann M; Fussenegger M
Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
